MedTrace Logo

Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study

NCT02037178 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-01-03

No results posted yet for this study

Summary

The main objective of this study is to evaluate the inter-observer concordance when measuring the maximum value of the external antero-posterior diameter of the sub-renal aorta (both cross-sectional and longitudinal ultrasound views are measured). The first measure is made by a general practitioner in private practice; second reading are made by an expert in vascular medicine.

Conditions

  • Peripheral Obliterative Arteriopathy

Interventions

OTHER

First ultrasound reading

First ultrasound reading of the sub-renal abdominal aorta by a general practitioner.

OTHER

Second ultrasound interpretation

The untrasound images recorded by general practitioners will be interpreted a second time by an expert in vascular medecine, and evaluated for their image quality.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • David Costa, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-28
Primary Completion
2017-12-20
Completion
2017-12-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037178 on ClinicalTrials.gov